This month, we welcome Dr. Gregory Piazza for an overview on cerebral venous sinus thrombosis (CVST), a rare condition that has recently been associated with the Johnson & Johnson COVID-19 vaccine. Dr. Piazza is an Associate Professor of Medicine at Harvard Medical School, Section Head of Vascular Medicine at Brigham and Women’s Hospital, and a member of NATF’s Board of Directors.
In this webinar, Dr. Piazza specifically discusses:
- What CVST is
- Risk factors for CVST
- Signs and symptoms
- Tools used to diagnose CVST
- Treatment strategies
- The prognosis of CVST (how the disease progresses)
- Although rare in the general population, CVST is more common among younger people, women, and patients with blood clotting disorders.
- There are four major syndromes that are typically seen in CVST, including increased pressure in the brain, problems with brain function, seizures, and certain changes in mental status.
- The diagnosis requires recognition of these syndromes + imaging.
- Anticoagulation (a blood thinner) is the key therapy for CVST.